ERYTHROPOIETIN (EPO) ENDOVENOUS VERSUS SUBCUTANEOUS TO PATIENTS ON CHRONIC-HEMODIALYSIS (CH)

被引:0
|
作者
AMAYA, L [1 ]
BONELLI, CA [1 ]
PEREZ, N [1 ]
CHAMORRO, A [1 ]
OLMOS, Z [1 ]
BRUSCO, P [1 ]
VELAZQUEZ, J [1 ]
GUITIAN, N [1 ]
CASTRO, I [1 ]
机构
[1] CENT MIL HOSP, BUENOS AIRES, ARGENTINA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1413 / 1413
页数:1
相关论文
共 50 条
  • [1] BLOOD-PRESSURE BEHAVIOR IN PATIENTS ON CHRONIC-HEMODIALYSIS (CH) TREATED WITH SUBCUTANEOUS AND ENDOVENOUS (EV) ERYTHROPOIETIN (EPO)
    AMAYA, L
    BONELLI, CA
    PEREZ, N
    CHAMORRO, A
    OLMOS, Z
    BRUSCO, P
    VELAZQUEZ, J
    GUITIAN, N
    CASTRO, I
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1413 - 1413
  • [2] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS ON CHRONIC-HEMODIALYSIS
    BARNAS, U
    WATZINGER, U
    PEER, G
    MAYER, G
    GRAF, H
    NEFROLOGIA, 1990, 10 : 116 - 120
  • [3] A CONTROLLED-STUDY OF RECOMBINANT ERYTHROPOIETIN (EPO) IN CHRONIC-HEMODIALYSIS PATIENTS
    VANSTONE, JC
    JONES, ME
    HIRES, CE
    CLINICAL RESEARCH, 1987, 35 (06): : A905 - A905
  • [4] A CONTROLLED-STUDY OF RECOMBINANT ERYTHROPOIETIN (EPO) IN CHRONIC-HEMODIALYSIS PATIENTS
    VANSTONE, JC
    JONES, ME
    HIRES, CE
    KIDNEY INTERNATIONAL, 1988, 33 (01) : 240 - 240
  • [5] WEEKLY SUBCUTANEOUS ERYTHROPOIETIN MAINTAINS HEMATOCRIT IN CHRONIC-HEMODIALYSIS PATIENTS
    PARKER, KP
    SANDS, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1993, 3 (10): : 1717 - 1718
  • [6] WEEKLY SUBCUTANEOUS ERYTHROPOIETIN MAINTAINS HEMATOCRIT IN CHRONIC-HEMODIALYSIS PATIENTS
    PARKER, KP
    LACOURSIERE, T
    MACON, EJ
    STIVELMAN, JC
    BAILEY, JL
    KIKERI, D
    MITCH, WE
    SANDS, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 470 - 470
  • [7] INFLUENCE OF ERYTHROPOIETIN (EPO) ON DIELECTRIC-PROPERTIES OF ERYTHROCYTES IN PATIENTS ON CHRONIC-HEMODIALYSIS
    RUTKOWSKI, B
    BAUTEMBACH, S
    DEBSKASLIZIEN, A
    NOWAK, J
    TERLECKI, J
    MANITIUS, A
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1993, 22 (06) : 246 - 248
  • [8] RECOMBINANT ERYTHROPOIETIN (EPO) THERAPY IN CHRONIC-HEMODIALYSIS PATIENTS IS FREQUENTLY ASSOCIATED WITH MACROCYTOSIS
    LAVER, MC
    MACCARTHY, EP
    CLYNE, DH
    POLLAK, VE
    KIDNEY INTERNATIONAL, 1989, 36 (06) : 1164 - 1165
  • [9] DEVELOPMENT AND DETECTION OF IRON (FE) DEFICIENCY IN CHRONIC-HEMODIALYSIS (CHD) PATIENTS ON ERYTHROPOIETIN (EPO)
    FINNEGAN, M
    SCHLIECHER, RB
    BABCOCK, SK
    SHAPIRO, JI
    SELIGMAN, PA
    CLINICAL RESEARCH, 1993, 41 (01): : A98 - A98
  • [10] EFFICACY OF SUBCUTANEOUS VS INTRAVENOUS MAINTENANCE THERAPY WITH ERYTHROPOIETIN IN CHRONIC-HEMODIALYSIS PATIENTS
    FREUDIGER, H
    GLUCK, Z
    KIDNEY INTERNATIONAL, 1991, 39 (06) : 1330 - 1330